SNAP-8 Powder (Bulk)

SNAP-8 Powder (Bulk) Product Profile

SNAP-8 Powder (Bulk) is an essential laboratory and formulation supply item required for professional peptide research and cosmetic compounding applications.

Product Specifications

Parameter	Value
Composition	C41H70N16O16S
Mol. Weight	1075.2 g/mol
Grade	Cosmetic Grade (>98%)
Appearance	White-to-off-white powder

Figure 1: SNAP-8 Powder (Bulk) Overview

Application Details

1. Bulk cosmetic-grade octapeptide for incorporation into anti-wrinkle formulations.
2. Competitively inhibits SNARE complex formation at the neuromuscular junction.
3. Prevents acetylcholine vesicle fusion with the presynaptic motor neuron membrane.
4. Reduces the intensity of facial muscle contractions causing dynamic expression lines.
5. Provides a topical, non-invasive mechanism mimicking Botulinum Toxin effects.

Figure 2: Quality Metrics

Key Notes

• 1: The leading raw ingredient for 'Botox-alternative' anti-wrinkle cream formulations.
• 2: Typically formulated at 3-10% concentration for maximum efficacy.
• 3: 1g and 10g quantities support both small-batch and commercial formulation scales.

Mechanism: Neuromuscular Signal Modulation

SNAP-8 (Acetyl Octapeptide-3) is an elongated analogue of the earlier SNAP-25-targeting pentapeptide Argireline. It competitively inhibits the formation of the SNARE complex—the protein machinery responsible for vesicle fusion at the neuromuscular junction. By interfering with the docking of synaptic vesicles, SNAP-8 attenuates the release of acetylcholine, reducing the intensity of muscular contractions that cause expression lines. Unlike botulinum toxin, this mechanism is dose-limited and fully reversible upon discontinuation.

1. SNAP-8 mimics the N-terminal domain of SNAP-25, a protein essential for synaptic vesicle docking.
2. The octapeptide competes with native SNAP-25 for binding sites on the SNARE complex (syntaxin + VAMP).
3. Partial SNARE complex inhibition reduces, but does not eliminate, acetylcholine exocytosis at the motor end plate.
4. Reduced neurotransmitter release produces a measurable relaxation of superficial mimetic muscles (frontalis, orbicularis oculi, corrugator).
5. Surface-level expression wrinkles (forehead, crow’s feet, glabellar lines) become visibly softer within 14–28 days of consistent topical application.

Formulation & Use in Anti-Aging Products

• Recommended Concentration: 3–10% in aqueous serums. Published cosmetic efficacy studies typically use 10% SNAP-8 solution (equivalent to approximately 0.05% w/v active peptide, as commercial stock solutions are supplied at 0.5% in water).
• Synergistic Actives: SNAP-8 performs well alongside hyaluronic acid, Matrixyl (palmitoyl pentapeptide-4), and Leuphasyl for comprehensive wrinkle-targeting protocols.
• Application Layer: Apply to cleansed, slightly damp skin before heavier cream or oil layers. The peptide is hydrophilic and requires direct epidermal contact for passive diffusion.
• Clinical Data: A 28-day double-blind study showed a 35% average reduction in wrinkle depth at 10% concentration versus 10% reduction in placebo, measured by silicone replica profilometry.
• Safety Profile: Non-cytotoxic in standard Draize and MTT assays. No sensitization observed in repeat insult patch testing (RIPT) at concentrations up to 10%.

Raw Powder Handling

SNAP-8 powder is hygroscopic and should be stored sealed under inert atmosphere (nitrogen flush) at −20°C for archival stability or 2–8°C for active use. Reconstitute in sterile distilled water to create a stock solution. The peptide is stable in the pH range of 5.0–7.0. Avoid exposure to strong oxidizers or heavy metal contaminants that may cleave the peptide backbone. Bulk powder is white to off-white; any yellowing indicates degradation and the batch should be discarded.